Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
I'm not an attorney, but one thing Hikma | Jim Nasium | investorshub | 07/18/2024 6:16:54 PM |
Lets stop calling it a vaccine. | KnowNothingJonSnow | investorshub | 07/18/2024 6:16:24 PM |
Joe Biden has COVID, he was vaccinated too. | Nukemtiltheyglow | investorshub | 07/18/2024 6:09:22 PM |
Thanks for the post Capt: I'm debating on | Nukemtiltheyglow | investorshub | 07/18/2024 5:30:18 PM |
https://x.com/GeoWizz /status/1813950701783150743 | CaptBeer | investorshub | 07/18/2024 5:26:30 PM |
Mic drop!!! What no rebuttal? | Nukemtiltheyglow | investorshub | 07/18/2024 4:47:28 PM |
It was great! I would have rather | RT Vegas | investorshub | 07/18/2024 3:46:13 PM |
Thanks Bob; only a matter of time. Spain | Nukemtiltheyglow | investorshub | 07/18/2024 2:59:40 PM |
A number of posters (thinking Orbapu here) have | rosemountbomber | investorshub | 07/18/2024 2:39:49 PM |
JRoon, Nothing has changed? Do you think Teva | Number sleven | investorshub | 07/18/2024 2:15:47 PM |
I'm sure that will get worked out in | JRoon71 | investorshub | 07/18/2024 2:09:51 PM |
JRoon, Doesn't have CVD listed as a limitation | Number sleven | investorshub | 07/18/2024 2:01:48 PM |
ABC, my assumption is that they were just | JRoon71 | investorshub | 07/18/2024 1:55:07 PM |
JROON, I notice that Camber avoided the CV indication | antibluechip | investorshub | 07/18/2024 1:44:53 PM |
Clearing the $0.80 hurdle in PM | JRoon71 | investorshub | 07/18/2024 12:50:19 PM |
RT- thanks for the awesome trip idea. I | Skipperdog11 | investorshub | 07/18/2024 12:17:38 PM |
https://www.pacermonitor.com/public/case/40022951/DR REDDYS LABORATORIES INC v A | Number sleven | investorshub | 07/18/2024 8:41:32 AM |
IMO you cannot really rely on numbers provided | Denisk | investorshub | 07/18/2024 12:29:37 AM |
If I retired there I would weigh 800 | RT Vegas | investorshub | 07/17/2024 11:31:48 PM |
Interesting. Less CV incidence in Portugal but | rosemountbomber | investorshub | 07/17/2024 10:48:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...